Back to Agenda
Updates from The Middle East – A Leap Forward in Digitalization and Steps Towards Faster Access
Session Chair(s)
Catherine Al Ashram
Executive Director Regulatory Affairs & PV Lead, EEMEA
Organon, Jordan
The session will be structured as a panel discussion with key regulators and industry leaders from MERN.
Speaker(s)
Saudi FDA Flexibilities During the COVID-19 Pandemic
Bandar Al Hammad, MPharm
Saudi Food and Drug Authority (SFDA), Saudi Arabia
Chief Pharmacist, Regulatory Affairs Department
Steps forward for Faster Access and Emergency Use during the COVID-19 Crisis
Amal Ahmad
Jordan Food and Drug Administration (JFDA), Jordan
Drug Directorate Director
UAE MOHAP: Digitalization and Business Continuity During the COVID-19 Pandemic
Mona Ali AL Hammadi
Ministry of Health and Prevention (MOHAP), United Arab Emirates
Head of Conventional Medicines New Registration Unit
The WHO Perspective
Samvel Azatyan, MD, PhD
World Health Organization (WHO), Switzerland
Team Lead, Regulatory Convergence and Networks (RCN/REG)
Panelist
May Bo Shaibah
Ministry of Health, Kuwait
Registration and Release Superintendent
Panelist
Ahmed M HUSSEIN Babiker, MSc, RPh
Ministry of Public Health, Qatar
Head, Drug Registration & Pricing Section
Have an account?